Top Markets
Coin of the day
NeuroSense Therapeutics Ltd. NeuroSense Therapeutics Ltd.

NeuroSense Therapeutics Ltd.

NRSN
Rank in Stocks #31074
NeuroSense Therapeutics Ltd. operates as a biotechnology firm in the clinical... NeuroSense Therapeutics Ltd. operates as a biotechnology firm in the clinical development phase, committed to discovering and developing effective therapies for individuals suffering from severe neurodegenerative conditions. The company's leading drug candidate, PrimeC, is an innovative oral formulation that has successfully concluded Phase IIa clinical investigations for the management of amyotrophic lateral sclerosis (ALS). Additionally, its early-stage research pipeline features StabiliC, a potential treatment for Parkinson's disease, and CogniC, which is under development for Alzheimer's disease. Established in 2017, NeuroSense Therapeutics Ltd. is headquartered in Herzliya, Israel.
Share Price
$0.404
Market Cap
$14.28M
Change (1 day)
-10.42%
Change (1 year)
-67.68%
Country
IL
Trade NeuroSense Therapeutics Ltd. (NRSN)

Category

Stock price history for NeuroSense Therapeutics Ltd. (NRSN)
Highest end of day price: $0.47 on 2026-08-01

Lowest end of day price: $3.04 on 2021-12-01
Stock price history of NeuroSense Therapeutics Ltd. from 2021 to 2026
Annual Stock Price Performance
Year Performance
2026 (TTM) -1.04%
2025 -17.69%
2024 31.68%
2023 -42.23%
2022 -51.82%
2021 0.00%
Stock price for similar companies or competitors
Company Stock price Change 1y% Country
$529.92 35.92%
US
$1.01K 52.16%
NL
$111.31 -36.83%
AU
$735.86 6.87%
CH
$257.75 13.01%
BE